United States
Germany
Japan
United Kingdom
China
Lenti ORF clone of Human sialidase 1 (lysosomal sialidase) (NEU1), mGFP tagged
| Type | Human Tagged ORF Clone |
| Tag | mGFP |
| Vector | pLenti-C-mGFP |
- LentiORF®
Products
NEU1 HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
NEU1 - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 GFP-puro donor, 1 scramble control |
| Donor DNA | GFP-puro |
NEU1 mouse monoclonal antibody, clone OTI3F5 (formerly 3F5)
| Applications | WB |
| Reactivities | Human |
NEU1 mouse monoclonal antibody, clone OTI3B8 (formerly 3B8)
| Applications | WB |
| Reactivities | Human |
NEU1 mouse monoclonal antibody, clone OTI3H2 (formerly 3H2)
| Applications | WB |
| Reactivities | Human |
NEU1 mouse monoclonal antibody, clone OTI3H4 (formerly 3H4)
| Applications | WB |
| Reactivities | Human |
NEU1 mouse monoclonal antibody, clone OTI3C5 (formerly 3C5)
| Applications | WB |
| Reactivities | Human |
Purified recombinant protein of Human sialidase 1 (lysosomal sialidase) (NEU1)
| Tag | C-His |
| Expression Host | HEK293 |
NEU1 (untagged)-Human sialidase 1 (lysosomal sialidase) (NEU1)
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL4 |
NEU1 - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 Luciferase-Puro donor, 1 scramble control |
| Donor DNA | Luciferase-Puro |
NEU1 - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 RFP-BSD donor, 1 scramble control |
| Donor DNA | RFP-BSD |
NEU1 - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 mBFP-Neo donor, 1 scramble control |
| Donor DNA | mBFP-Neo |
NEU1 MS Standard C13 and N15-labeled recombinant protein (NP_000425)
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
Lenti ORF clone of Human sialidase 1 (lysosomal sialidase) (NEU1), Myc-DDK-tagged
| Type | Human Tagged ORF Clone |
| Tag | Myc-DDK |
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
- LentiORF®
